Transplantation of embryonic marmoset dopaminergic neurons to the corpus striatum of marmosets rendered parkinsonian by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine

Progress in Brain Research

Volumn 78, Issue C, 1988, Pages 479-489

  Fine, A ^a   Hunt, S P ^b   Bond, A ^b   Waters, C ^b   Oertel, W H ^b   Nomoto, M ^b   Chong, P N ^b   Temlett, J A ^b   Jenner, P ^b   Marsden, C D ^b   Annett, L ^c   Dunnett, S ^c  

^a DALHOUSIE UNIVERSITY   (Canada)

^b MEDICAL RESEARCH COUNCIL   (United Kingdom)

^c UK   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

1,2,3,6 TETRAHYDRO 1 METHYL 4 PHENYLPYRIDINE; AMPHETAMINE; BENSERAZIDE; LEVODOPA;

ADULT; ANIMAL CELL; ANIMAL EXPERIMENT; BEHAVIOR; CONTROLLED STUDY; CORPUS STRIATUM; DEVELOPMENT; DOPAMINERGIC NERVE CELL; EMBRYO; HISTOLOGY; INTRAPERITONEAL DRUG ADMINISTRATION; MAMMAL; MARMOSET; NERVE GRAFT; NONHUMAN; PARKINSON DISEASE; PSYCHOLOGICAL ASPECT;

EID: 0024262022     PISSN: 00796123     EISSN: 18757855     Source Type: Book Series    
DOI: 10.1016/S0079-6123(08)60321-0     Document Type: Article

References (27)

1. K.S. Bankiewicz, R.J. Plunkett, I.J. Kopin, D.M. Jacobowitz, W.T. London, E.H. Oldfield, (1988) Transient behavioral recovery in hemiparkinsonian primates after adrenal medullary allografts. In D. M. Gash and J.R. Sladek, Jr. (Eds), Transplantation into the Mammalian Central Nervous System, Progress in Brain Research (this volume).
2. Bernheimer, H., Birkmayer, W., Hornykiewicz, O., Jellinger, K., Seitelberger, F., Brain dopamine and the syndromes of Parkinson and Huntington. J. Neurol. Sci. 20 (1973), 415–455.
3. Björklund, A., Stenevi, U., Neural Grafting in the Mammalian CNS, 1985, Elsevier, Amsterdam.
4. Burns, R.S., Chiueh, C.C., Markey, S.P., Ebert, M.H., Jacobowitz, D.M., Kopin, I.J., A primate model of parkinsonism: Selective destruction of dopaminergic neurons in the pars compacta of the substantia nigra by N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine. Proc. Natl. Acad. Sci. USA 80 (1983), 4546–4550.
5. Davis, G.C., Williams, A.C., Markey, S.P., Ebert, M.H., Caine, E.D., Reichert, C.M., Kopin, I.J., Chronic Parkinsonism secondary to intravenous injection of meperidine analogues. Psychiatr. Res. 1 (1979), 249–254.
6. De Quidt, M.E., Emson, P.C., Neuropeptide Y in the adrenal gland: characterisation, distribution and drug effects. Neuroscience 19 (1986), 1011–1022.
7. Deutch, A.V., Elsworth, J.D., Goldstein, M., Fuxe, K., Redmond, D.E. Jr, Sladek, J.R. Jr., Roth, R.H., Preferential vulnerability of A8 dopamine neurons in the primate to the neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine. Neurosci. Lett. 68 (1986), 51–56.
8. M. Dubach, R.H. Schmidt, R. Martin, D.C. German, D.M. Bowden, (1988) Transplant improves hemiparkinsonian syndrome in nonhuman primate: Intracerebral injection, rotometry, tyrosine hydroxylase immunohistochemistry. In D. M. Gash and J.R. Sladek, Jr. (Eds), Transplantation into the Mammalian Central Nervous System, Progress in Brain Research (this volume).
9. Fine, A., Reynolds, G.P., Nakajima, N., Jenner, P., Marsden, C.D., Acute administration of MPTP affects the adrenal glands as well as the brain in the marmoset. Neurosci. Lett. 58 (1985), 123–126.
10. Haber, S., Elde, R., The distribution of enkephalin immunoreactive fibres and terminals in the monkey central nervous system: an immunohistochemical study. Neuroscience 7 (1982), 1049–1095.
11. Herman, J.-P., Choulli, K., Le Moal, M., Hyperreactivity to amphetamine in rats with dopaminergic grafts. Exp. Brain Res. 60 (1985), 521–526.
12. Jenner, P., Marsden, C.D., The actions of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in animals as a model of Parkinson's disease. J. Neural Transm. Suppl. 20 (1986), 11–39.
13. Jenner, R., Rupniak, N.M.J., Rose, S., Kelly, E., Kilpatrick, G., Lees, A., Marsden, C.D., 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced parkinsonism in the common marmoset. Neurosci. Lett. 50 (1984), 85–90.
14. Kitt, C.A., Cork, L.C., Eidelberg, F., Joh, T.H., Price, D.L., Injury of nigral neurons exposed to MPTP: a tyrosine hydroxylase immunohistochemical study in monkey. Neuroscience 17 (1986), 1089–1103.
15. Langston, J.W., Ballard, P., Tetrud, J.W., Irwin, I., Chronic parkinsonism in humans due to a product of meperidine-anaiog synthesis. Science 219 (1983), 979–980.
16. Langston, J.W., Forno, L.S., Rebert, C.S., Irwin, I., Selective nigral toxicity after systemic administration of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) in the squirrel monkey. Brain Res. 292 (1984), 390–394.
17. Lee, T., Seeman, P., Rajput, A., Farley, I.J., Hornykiewicz, O., Receptor basis for dopaminergic supersensitivity in Parkinson's disease. Nature 273 (1978), 59–61.
18. Mitchell, I.J., Cross, A.J., Sambrock, M.A., Crossman, A.R., Neural mechanisms mediating MPTP-induced parkinsonism in the monkey: relative contributions of the striatopallidal and striatonigral pathways as suggested by 2-deoxy-glucose uptake. Neurosci. Lett. 63 (1986), 61–65.
19. Nagy, J.I., Goedert, M., Hunt, S.P., Bond, A., The nature of the substance P-containing nerve fibres in the taste papillae of the rat tongue. Neuroscience 7 (1982), 3137–3151.
20. Oertel, W.H., Schmechel, D.E., Tappaz, M.L., Kopin, I.J., Production of a specific antiserum to rat brain glutamic acid decarboxylase by injection of an antigenantibody complex. Neuroscience 6 (1981), 2689–2700.
21. Redmond, D.E., Sladek, J.R. Jr., Roth, R.H., Collier, T.J., Elsworth, J.D., Deutch, A.Y., Haber, S., Fetal neuronal grafts in monkeys given methylphenyltetrahydropyridine. Lancet 1 (1986), 1125–1127.
22. Schmidt, R.H., Björklund, A., Stenevi, U., Dunnett, S.B., Gage, F.H., Activity of intrastriatal nigral suspension implants as assessed by measurements of dopamine synthesis and metabolism. Acta Physiol. Scand. Suppl. 522 (1983), 19–28.
23. Schneider, J.S., Yuwiler, A., Markham, C.H., Selective loss of subpopulations of ventral mesencephalic dopaminergic neurons in the monkey following exposure to MPTP. Brain Res. 411 (1987), 144–150.
24. J.R. Sladek Jr. D.E. Redmond, T.J. Collier, J.P. Blount, J.D. Elsworth, J.T. Taylor, R.H. Roth, (1988) Fetal dopamine neural grafts: extended reversal of methylphenyl-tetrahydroxypyridine-induced parkinsonism in monkeys. In D. M. Gash and J.R. Sladek, Jr. (Eds.), Transplantation into the Mammalian Central Nervous System. Progress in Brain Research (this volume).
25. Ueki, A., Chong, P.N., Albanese, A., Nomoto, M., Rose, S., Gibb, W.R., Jenner, P., Marsden, C.D., Brain dopamine function and responses to MPTP in common marmosets treated with MPTP up to 18 months previously. Br. J. Pharmacol., 92(Supplement), 1987, 701.
26. Waters, C.M., Hunt, S.P., Bond, A.B., Jenner, P., Marsden, C.D., Neuropathological, immunohistochemical and receptor changes seen in marmosets treated with MPTP. Markey, S.P., Castagnoli, N. Jr., Trevor, A.J., Kopin, I.J., (eds.) MPTP: A Neurotoxin Producing a Parkinsonian Syndrome, 1986, Academic Press, New York, 637–642.
27. Waters, C.M., Hunt, S.P., Jenner, P., Marsden, C.D., An immunohistochemical study of the acute and longterm effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in the marmoset. Neuroscience 23 (1987), 1025–1039.